Bakhtier Nurmukhamedov M.D.

Recommended Articles

• Understanding the Relationship Between Constipation and Parkinson’s

  As technology progresses, understanding about the intensive dialogue between the gut and the brain is also getting better. It is now understood that if things go wrong with this exchange, it is terrible for both of them. Changes in the activity of the gut may worsen the functioning of the brain,...

• Hospital Outcomes Proven to Be Worse for Dementia Patients

  Patients with delirium or dementia have inferior treatment during hospital stays, a large population study from the University of Stirling shows. Professor Emma Reynish, the study’s author and lead researcher, uncovered markedly different results in outcomes.“People who are admitted to hospital...

• Absence Epilepsy

  Epilepsy is a disorder of the nervous system that causes seizures. Absence seizures, also called petit mal seizures, are brief seizures which usually last for 15 seconds or less. These seizures are so short that symptoms may not even be noticed. However, if an absence seizure is accompanied by loss...

• Jiffy Lube Steps Up to Join the 6th Muscle Up Muscular Dystrophy Fundraiser

  Muscular dystrophy is a serious condition wherein one will lose a lot of muscle mass and have weaker muscles. The cause of muscular dystrophy is said to be the presence of mutations from a person’s genetics that would stop the production of a protein that forms the muscles. Symptoms can mostly be...

• Literally Fighting Parkinson's: Fitness Program Focuses on Boxing to Alleviate Symptoms

  “Exercise is good for the brain” is a statement largely supported by scientists, physicians, researchers and all kinds of experts in the field of neurology. Some of the benefits the brain can receive from regular exercise are:...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...